Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Neurology Journal

Fecha de publicación: 8 August 2019


Autores: Shivani Ahlawat, Jaishri O. Blakeley, Fausto J. Rodriguez, Laura M. Fayad

Background: To determine the utility of quantitative metrics obtained from fMRI using diffusion-weighted imaging (DWI)/apparent diffusion coefficient (ADC) mapping compared with metabolic (18F-fluorodeoxyglucose [FDG]-PET/CT) imaging in patients with neurofibromatosis type 1 (NF1) for the characterization of peripheral nerve sheath tumors (PNSTs) as benign or malignant.

Seguir leyendo

Enviar comentario